Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Rhijn, B.W.G. van
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(8)
+
-
Availability
Open access
(4)
+
-
Metadata Only
(4)
+
-
Creation Date
2010
(2)
+
-
2021
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(6)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(6)
+
-
Scholarly Publications
(2)
+
-
Author
Rhijn, B.W.G. van
(8)
+
-
Gennep, E.J. van
(4)
+
-
Mertens, L.S.
(4)
+
-
Poel, H.G. van der
(4)
+
-
Donswijk, M.L.
(3)
+
-
Hendricksen, K.
(3)
+
-
Aa, M.N.M. van der
(2)
+
-
Einerhand, S.M.H.
(2)
+
-
Kwast, T.H. van der
(2)
+
-
Vegt, E.
(2)
+
-
Voskuilen, C.S.
(2)
+
-
Zwarthoff, E.C.
(2)
+
-
Show more
Language
en
(8)
+
-
Search results
(1 - 8 of 8)
show grid
show list
save search
Added clinical value of 18F-FDG-PET/CT to stage patients with high-risk non-muscle invasive bladder cancer before radical cystectomy
Staging 18F-fluorodeoxyglucose positron emission tomography/computed tomography changes treatment recommendation in invasive bladder cancer
Occult lymph node metastases in patients without residual muscle-invasive bladder cancer at radical cystectomy with or without neoadjuvant chemotherapy
Sexual satisfaction in men suffering from erectile dysfunction after robot-assisted radical prostatectomy for prostate cancer
F-18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in muscle-invasive bladder cancer
Sentinel node biopsy for bladder cancer using ICG-Tc-99m-nanocolloid
FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy
Cystoscopy revisited as the gold standard for detecting bladder cancer recurrence: diagnostic review bias in the randomized, prospective CEFUB trial